Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jan 15:362:577784.
doi: 10.1016/j.jneuroim.2021.577784. Epub 2021 Dec 8.

Stellate ganglion block reduces symptoms of Long COVID: A case series

Affiliations
Case Reports

Stellate ganglion block reduces symptoms of Long COVID: A case series

Luke D Liu et al. J Neuroimmunol. .

Abstract

After recovering from COVID-19, a significant proportion of symptomatic and asymptomatic individuals develop Long COVID. Fatigue, orthostatic intolerance, brain fog, anosmia, and ageusia/dysgeusia in Long COVID resemble "sickness behavior," the autonomic nervous system response to pro-inflammatory cytokines (Dantzer et al., 2008). Aberrant network adaptation to sympathetic/parasympathetic imbalance is expected to produce long-standing dysautonomia. Cervical sympathetic chain activity can be blocked with local anesthetic, allowing the regional autonomic nervous system to "reboot." In this case series, we successfully treated two Long COVID patients using stellate ganglion block, implicating dysautonomia in the pathophysiology of Long COVID and suggesting a novel treatment.

Keywords: Cerebral blood flow; Dysautonomia; Long COVID/PASC; Myalgic encephalitis/chronic fatigue syndrome (ME/CFS); Postural orthopedic tachycardia syndrome (POTS); Stellate ganglion block.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Intensity of Long COVID symptoms over time. Data was collected retrospectively for Pre-COVID timepoint. NOTE: Y axis set to −1 to visualize a score of zero.
Fig. 2
Fig. 2
Intensity of Long COVID symptoms over time. Data was collected retrospectively for Pre-COVID timepoint. NOTE: Y axis set to −1 to visualize a score of zero.

References

    1. Barizien N., Le Guen M., Russel S., et al. Clinical characterization of dysautonomia in long COVID-19 patients. Sci. Rep. 2021;11:14042. doi: 10.1038/s41598-021-93546-5. PMID: 34234251; PMCID: PMC8263555. - DOI - PMC - PubMed
    1. Dani M., Dirksen A., Taraborrelli P., Torocastro M., Panagopoulos D., Sutton R., Lim P.B. Autonomic dysfunction in ‘long COVID’: rationale, physiology and management strategies. Clin. Med. (Lond) 2021 Jan;21(1):e63–e67. doi: 10.7861/clinmed.2020-0896. Epub 2020 Nov 26. PMID: 33243837; PMCID: PMC7850225. - DOI - PMC - PubMed
    1. Dantzer R., O’Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008 Jan;9(1):46–56. doi: 10.1038/nrn2297. PMID: 18073775; PMCID: PMC2919277. - DOI - PMC - PubMed
    1. Kang C.K., Oh S.T., Chung R.K., Lee H., Park C.A., Kim Y.B., Yoo J.H., Kim D.Y., Cho Z.H. Effect of stellate ganglion block on the cerebrovascular system: magnetic resonance angiography study. Anesthesiology. 2010 Oct;113(4):936–944. doi: 10.1097/ALN.0b013e3181ec63f5. (PMID: 20823762) - DOI - PubMed
    1. Le Bert N., Clapham H.E., Tan A.T., Chia W.N., Tham C.Y.L., Lim J.M., Kunasegaran K., Tan L.W.L., Dutertre C.A., Shankar N., Lim J.M.E., Sun L.J., Zahari M., Tun Z.M., Kumar V., Lim B.L., Lim S.H., Chia A., Tan Y.J., Tambyah P.A., Kalimuddin S., Lye D., Low J.G.H., Wang L.F., Wan W.Y., Hsu L.Y., Bertoletti A., Tam C.C. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 2021 May 3;218(5) doi: 10.1084/jem.20202617. PMID: 33646265; PMCID: PMC7927662. - DOI - PMC - PubMed

Publication types